| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | -0.0072 | 0.8 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.0064 | 0.8 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | 0.0073 | 0.8 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.006 | 0.8 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.0065 | 0.9 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | 0.0071 | 0.9 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.009 | 0.9 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | -0.0091 | 0.9 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.0054 | 0.9 |